Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke "TARDIS"


Phase 3 Results N/A

Summary of Purpose

The risk of recurrence is greatest immediately after stroke or Transient Ischaemic Attack (TIA). Existing prevention strategies (antithrombotic, lipid/blood pressure lowering, endarterectomy) reduce, not abolish, further events. Dual antiplatelet therapy - aspirin & clopidogrel (AC) for IHD, aspirin & dipyridamole (AD)... Trial Stopped: Trial reached a definitive answer ahead of full recruitment.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 July 2016.

1 Apr 2009 23 Jul 2012 1 Sep 2016 1 Sep 2016 1 Jul 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Subject)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment